SharkScrew ACL RCT

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorAustrian Workers Compensation Board Styria

About this trial

This prospective, randomized controlled trial will compare three tibial interference screw types used for graft fixation during primary anterior cruciate ligament (ACL) reconstruction: a polyetheretherketone (PEEK) screw, a biocomposite screw, and an allograft bone screw. Although interference screws are widely used for tibial fixation, the optimal screw material remains uncertain, particularly regarding its effect on tibial tunnel widening and graft incorporation.

Adult patients undergoing primary ACL reconstruction with a quadriceps tendon autograft using a standardized surgical technique will be randomly assigned to one of the three tibial fixation methods. The primary outcome is tibial tunnel widening measured by computed tomography (CT) 12 months after surgery. Secondary outcomes include graft integration assessed by magnetic resonance imaging (MRI) and patient-reported clinical outcomes, including the Lysholm, Tegner, KOOS, and ACL-Return to Sport after Injury (ACL-RSI) scores, collected during routine follow-up. The study aims to determine whether allograft bone screws reduce tunnel widening and improve graft integration compared with PEEK and biocomposite screws while maintaining comparable clinical outcomes.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Male and non-pregnant female patients aged 18-70 years

MRI-confirmed rupture of the anterior cruciate ligament (ACL)

Clinically positive anterior drawer test and Lachman test

Subjective instability

Disqualifiers

Previous surgery on the affected knee joint (ACL reconstruction, fracture fixation, osteotomy, or partial joint replacement)

Body mass index (BMI) > 40

Coronal instability due to injury of the medial collateral ligament or posterolateral corner

Meniscal injury requiring postoperative restriction of weight-bearing (e.g., root tears, radial tears)

Trial design

Design model

Parallel

Treatments tested in this trial

  • ACL Reconstruction with a Biocomposite Screw

    Procedure/Surgery

    ACL Reconstruction using a standardized technique. Tibial Fixation using a Biocomposite Screw.

  • ACL Reconstruction using a PEEK Screw

    Procedure/Surgery

    ACL Reconstruction using a standardized technique. Tibial Fixation using a PEEK Screw.

  • ACL Reconstruction using an Allograft Screw

    Procedure/Surgery

    ACL Reconstruction using a standardized technique. Tibial Fixation using a SharkScrew Allograft Interference Screw.

Treatment groups

33 Participants
are divided into 3 treatment groups
Group A: Biocomposite Interference ScrewActive comparator 1 intervention
Group B: PEEK Interference ScrewActive comparator 1 intervention
Group C: Shark ScrewExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Tibial Tunnel Widening

CT Measurement of the tibial Tunnel Widening in mm. The difference will be calculated between drilled diameter and measured diameter.

Time frame
1 Year Postop

Secondary outcomes

1

MRI Graft Integration

MRI Graft Integration using SNL Coefficient. Baseline PCL graft signal on fat suppressed T2 will be compared to the ACL in 3 zones, tibial, intraarticular and femoral. The technique is described in detail in Putnis SE, Klasan A, Oshima T, Grasso S, Neri T, Coolican MRJ, Fritsch BA, Parker DA. Magnetic Resonance Imaging Assessment of Hamstring Graft Healing and Integration 1 and Minimum 2 Years after ACL Reconstruction. Am J Sports Med. 2022 Jul;50(8):2102-2110. doi: 10.1177/03635465221096672. Epub 2022 May 25. PMID: 35612835.

Time frame
6 Months and 1 Year
2

Lysholm

Lysholm Questionnaire scores will be assessed. Possible value 0-100. Higher is better.

Time frame
1 Year postop
3

Tegner

Tegner Questionnaire will be assessed. Range 0-10, higher is better.

Time frame
Preop, 1 year postop
4

ACL-RSI

ACL-RSI Questionnaire will be assessed. 0-100, higher is better.

Time frame
12 month postop

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: